Monoamine precursors in the treatment of depression | Zendy

Carroll Bernard J. | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Premium

Monoamine precursors in the treatment of depression

Author(s) -

Carroll Bernard J.

Publication year - 1971

Publication title -

clinical pharmacology and therapeutics

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.941

H-Index - 188

eISSN - 1532-6535

pISSN - 0009-9236

DOI - 10.1002/cpt1971125743

Subject(s) - monoamine neurotransmitter , tryptamine , norepinephrine , depression (economics) , serotonin , dopamine , psychiatry , medicine , psychology , pharmacology , neuroscience , economics , keynesian economics , receptor

The current biological theories of depression are united in postulating a role for brain monoamine deficiency in this group of disorders. The relative importance of the various amines, dopamine (DA), norepinephrine ( NE ), serotonin (5–HT ) and tryptamine, is still unsettled, and several versions of the monoamine deficit theory of depression have been put forward with emphasis on one or other of these compounds. 5 , 56 , 94 , 128

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here

Accelerating Research